Histone Deacetylase Inhibitors Relax Mouse Aorta Partly through Their Inhibitory Action on L-Type Ca2+ Channels

J Pharmacol Exp Ther. 2017 Nov;363(2):211-220. doi: 10.1124/jpet.117.242685. Epub 2017 Aug 31.

Abstract

Histone deacetylase (HDAC) inhibitors modulate acetylation/deacetylation of histone and nonhistone proteins. They have been widely used for cancer treatment. However, there have been only a few studies investigating the effect of HDAC inhibitors on vascular tone regulation, most of which employed chronic treatment with HDAC inhibitors. In the present study, we found that two hydroxamate-based pan-HDAC inhibitors, suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA), could partially but acutely relax high extracellular K+-contracted mouse aortas. SAHA and TSA also attenuated the high extracellular K+-induced cytosolic Ca2+ rise and inhibited L-type Ca2+ channel current in whole-cell patch-clamp. These data demonstrate that SAHA could inhibit L-type Ca2+ channels to cause vascular relaxation. In addition, SAHA and TSA dose dependently relaxed the arteries precontracted with phenylephrine. The relaxant effect of SAHA and TSA was greater in phenylephrine-precontracted arteries than in high K+-contracted arteries. Although part of the relaxant effect of SAHA and TSA on phenylephrine-precontracted arteries was related to L-type Ca2+ channels, both agents could also induce relaxation via a mechanism independent of L-type Ca2+ channels. Taken together, HDAC inhibitors SAHA and TSA can acutely relax blood vessels via their inhibitory action on L-type Ca2+ channels and via another L-type Ca2+ channel-independent mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / drug effects*
  • Aorta / metabolism
  • Aorta / physiology*
  • Biological Transport / drug effects
  • Calcium / metabolism
  • Calcium Channels, L-Type / metabolism*
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Electrophysiological Phenomena / drug effects
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Histone Deacetylase Inhibitors / pharmacology*
  • Hydroxamic Acids / pharmacology*
  • Male
  • Mice
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / metabolism
  • Phenylephrine / pharmacology
  • Potassium / metabolism
  • Vasodilation / drug effects*
  • Vorinostat

Substances

  • Calcium Channels, L-Type
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Phenylephrine
  • trichostatin A
  • Vorinostat
  • Potassium
  • Calcium